Pump thrombosis
Pump thrombosis | |
---|---|
Synonyms | |
Pronounce | N/A |
Specialty | N/A |
Symptoms | Heart failure, shortness of breath, fatigue, chest pain |
Complications | Stroke, heart attack, device malfunction |
Onset | |
Duration | |
Types | |
Causes | Blood clot formation in ventricular assist device |
Risks | Mechanical heart valve, coagulation disorders, inadequate anticoagulation |
Diagnosis | Echocardiography, blood tests, device interrogation |
Differential diagnosis | |
Prevention | Adequate anticoagulation therapy, regular device monitoring |
Treatment | Anticoagulation, thrombolysis, device replacement |
Medication | N/A |
Prognosis | Variable, depending on severity and treatment |
Frequency | |
Deaths |
Pump thrombosis is a serious complication associated with the use of ventricular assist devices (VADs), which are mechanical pumps used to support heart function and blood flow in individuals with weakened hearts. This condition involves the formation of a blood clot within the pump, which can lead to device malfunction and serious clinical consequences.
Pathophysiology
Pump thrombosis occurs when a thrombus forms within the ventricular assist device. This can obstruct blood flow, leading to increased pump power consumption and potential device failure. The formation of a thrombus is influenced by several factors, including blood flow dynamics, shear stress, and the coagulation cascade.
Risk Factors
Several risk factors contribute to the development of pump thrombosis:
- Hypercoagulability: Conditions that increase the tendency of blood to clot can predispose patients to pump thrombosis.
- Device-related factors: The design and material of the VAD can influence thrombosis risk. Some devices have higher thrombosis rates due to their design.
- Suboptimal anticoagulation: Inadequate anticoagulation therapy can lead to thrombus formation.
- Patient-related factors: Individual patient characteristics, such as genetic predisposition and comorbidities, can affect thrombosis risk.
Clinical Presentation
Patients with pump thrombosis may present with:
- Dyspnea
- Fatigue
- Signs of heart failure
- Hemolysis, indicated by elevated lactate dehydrogenase (LDH) levels
- Device alarms indicating increased power consumption
Diagnosis
The diagnosis of pump thrombosis involves a combination of clinical assessment and diagnostic tests:
- Echocardiography: Used to assess heart function and detect thrombus formation.
- Blood tests: Elevated LDH and plasma-free hemoglobin levels can indicate hemolysis due to pump thrombosis.
- Device interrogation: Analyzing device parameters such as power consumption and flow rates can help identify thrombosis.
Management
Management of pump thrombosis includes:
- Anticoagulation therapy: Intensifying anticoagulation to prevent further thrombus formation.
- Thrombolysis: Use of thrombolytic agents to dissolve the thrombus.
- Device replacement: In severe cases, surgical replacement of the VAD may be necessary.
Prognosis
The prognosis of pump thrombosis depends on the timeliness and effectiveness of treatment. Prompt intervention can prevent serious complications such as stroke and heart failure.
Prevention
Preventive strategies include:
- Optimizing anticoagulation therapy to maintain therapeutic levels.
- Regular monitoring of device function and patient status.
- Use of devices with lower thrombosis risk profiles.
See Also
Cardiovascular disease A-Z
Most common cardiac diseases
- Cardiac arrhythmia
- Cardiogenetic disorders
- Cardiomegaly
- Cardiomyopathy
- Cardiopulmonary resuscitation
- Chronic rheumatic heart diseases
- Congenital heart defects
- Heart neoplasia
- Ischemic heart diseases
- Pericardial disorders
- Syndromes affecting the heart
- Valvular heart disease
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
A
- Accelerated idioventricular rhythm
- Acute decompensated heart failure
- Arteriosclerotic heart disease
- Athletic heart syndrome
- Atrial flutter
- Atrioventricular fistula
- Cardiovascular disease in Australia
- Autoimmune heart disease
B
C
- Ebb Cade
- Cardiac allograft vasculopathy
- Cardiac amyloidosis
- Cardiac asthma
- Cardiac tamponade
- Cardiogenic shock
- Cardiogeriatrics
- Cardiorenal syndrome
- Cardiotoxicity
- Carditis
- Coronary artery aneurysm
- Coronary artery anomaly
- Coronary artery disease
- Spontaneous coronary artery dissection
- Coronary artery ectasia
- Coronary occlusion
- Coronary steal
- Coronary thrombosis
- Coronary vasospasm
- Cœur en sabot
- Coxsackievirus-induced cardiomyopathy
D
E
H
- Heart attack
- Heart failure
- Heart failure with preserved ejection fraction
- Heart to Heart (1949 film)
- High-output heart failure
- Hyperdynamic precordium
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
I
- Idiopathic giant-cell myocarditis
- Interventricular dyssynchrony
- Intraventricular dyssynchrony
- Isolated atrial amyloidosis
K
L
M
- Mydicar
- Myocardial bridge
- Myocardial disarray
- Myocardial rupture
- Myocardial scarring
- Myocardial stunning
- Myocarditis
N
O
P
- Papillary fibroelastoma
- Pathophysiology of heart failure
- Postpericardiotomy syndrome
- Pulmonary vein stenosis
R
S
- Saturated fat and cardiovascular disease
- SCAR-Fc
- Shone's syndrome
- Strain pattern
- Subacute bacterial endocarditis
- Sudden cardiac death of athletes
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
T
V
W
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD